Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Drug Therapy, Combination × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

HR+HER2- Advanced Breast Cancer 1

Interventions

Blood Specimen Collection 121 Surveys and Questionnaires 113 Specimen Handling 53 Observation 42 Radiotherapy 36 Interviews as Topic 35 Drug Therapy 29 Biopsy 28 Surgical Procedures, Operative 28 Magnetic Resonance Spectroscopy 27 Immune Checkpoint Inhibitors 22 Data Collection 21 Nivolumab 19 Magnetic Resonance Imaging 18 Therapeutics 17 Watchful Waiting 17 Liquid Biopsy 16 Immunotherapy 15 Standard of Care 14 Focus Groups 12 Radiosurgery 12 Tomography, X-Ray Computed 12 enzalutamide 12 palbociclib 12 pembrolizumab 12 trastuzumab deruxtecan 12 Bevacizumab 11 Hematologic Tests 11 Positron Emission Tomography Computed Tomography 11 apalutamide 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06148506 2025-12-05

ValerEE

Novartis

Active not recruiting

HR+HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡